Published in Mol Psychiatry on April 15, 2014
Adjunctive raloxifene treatment improves attention and memory in men and women with schizophrenia. Mol Psychiatry (2015) 0.92
Selective Estrogen Receptor Modulation Increases Hippocampal Activity during Probabilistic Association Learning in Schizophrenia. Neuropsychopharmacology (2015) 0.92
Estrogen receptors in the central nervous system and their implication for dopamine-dependent cognition in females. Horm Behav (2015) 0.84
Rapid modulation of synaptogenesis and spinogenesis by 17β-estradiol in primary cortical neurons. Front Cell Neurosci (2015) 0.80
Potential Role of Oestrogen Modulation in the Treatment of Neurocognitive Deficits in Schizophrenia. CNS Drugs (2016) 0.78
Utilizing induced pluripotent stem cells (iPSCs) to understand the actions of estrogens in human neurons. Horm Behav (2015) 0.77
Raloxifene adjunctive therapy for postmenopausal women suffering from chronic schizophrenia: a randomized double-blind and placebo controlled trial. Daru (2014) 0.77
A Role for Estrogen in Schizophrenia: Clinical and Preclinical Findings. Int J Endocrinol (2015) 0.76
Adjunctive selective estrogen receptor modulator increases neural activity in the hippocampus and inferior frontal gyrus during emotional face recognition in schizophrenia. Transl Psychiatry (2016) 0.76
Celecoxib Adjunctive Treatment to Antipsychotics in Schizophrenia: A Review of Randomized Clinical Add-On Trials. Mediators Inflamm (2016) 0.76
Raloxifene as an Adjunctive Treatment for Postmenopausal Women With Schizophrenia: A 24-Week Double-Blind, Randomized, Parallel, Placebo-Controlled Trial. Schizophr Bull (2015) 0.76
Effects of sex, menstrual cycle phase, and endogenous hormones on cognition in schizophrenia. Schizophr Res (2015) 0.75
Improvement of Psychotic Symptoms and the Role of Tissue Plasminogen Activator. Int J Mol Sci (2015) 0.75
Analyzing the influence of BDNF heterozygosity on spatial memory response to 17β-estradiol. Transl Psychiatry (2015) 0.75
Catamenial psychosis in an adolescent girl. BMJ Case Rep (2014) 0.75
Why estrogens matter for behavior and brain health. Neurosci Biobehav Rev (2016) 0.75
Treatment of Endometriosis with the GnRHa Deslorelin and Add-Back Estradiol and Supplementary Testosterone. Biomed Res Int (2015) 0.75
Estrogen Signaling as a Therapeutic Target in Neurodevelopmental Disorders. J Pharmacol Exp Ther (2016) 0.75
Neuroactive Steroids in First-Episode Psychosis: A Role for Progesterone? Schizophr Res Treatment (2016) 0.75
The Neurobiological Basis for Social Affiliation in Autism Spectrum Disorder and Schizophrenia. Curr Behav Neurosci Rep (2016) 0.75
A power primer. Psychol Bull (1992) 63.66
The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull (1987) 51.07
A new depression scale designed to be sensitive to change. Br J Psychiatry (1979) 36.40
A rating scale for extrapyramidal side effects. Acta Psychiatr Scand Suppl (1970) 10.05
Epidemiology of puerperal psychoses. Br J Psychiatry (1987) 4.46
The emerging role of glutamate in the pathophysiology and treatment of schizophrenia. Am J Psychiatry (2001) 3.20
What does the PANSS mean? Schizophr Res (2005) 2.86
Sex differences in the risk of schizophrenia: evidence from meta-analysis. Arch Gen Psychiatry (2003) 2.41
Neuroprotection by estradiol. Prog Neurobiol (2001) 2.32
Dopamine receptors and the dopamine hypothesis of schizophrenia. Synapse (1987) 2.08
Estrogen replacement in perimenopause-related depression: a preliminary report. Am J Obstet Gynecol (2000) 1.80
Estrogen in severe mental illness: a potential new treatment approach. Arch Gen Psychiatry (2008) 1.78
Association of estrogen levels with neuropsychological performance in women with schizophrenia. Am J Psychiatry (2001) 1.57
Non-genomic actions of estrogens and their interaction with genomic actions in the brain. Front Neuroendocrinol (2007) 1.56
Actions of estrogens on glial cells: Implications for neuroprotection. Biochim Biophys Acta (2009) 1.46
Estrogen control of central neurotransmission: effect on mood, mental state, and memory. Cell Mol Neurobiol (1996) 1.42
The role of serotonin receptors in the action of atypical antipsychotic drugs. Curr Opin Pharmacol (2011) 1.38
Treatment of schizophrenia negative symptoms: future prospects. Schizophr Bull (2006) 1.35
Estrogen - a potential treatment for schizophrenia. Schizophr Res (2001) 1.34
Extranuclear estrogen receptors mediate the neuroprotective effects of estrogen in the rat hippocampus. PLoS One (2010) 1.30
Quantitative microdialysis determination of extracellular striatal dopamine concentration in male and female rats: effects of estrous cycle and gonadectomy. Neurosci Lett (1994) 1.24
An animal model for the effects of estradiol on dopamine-mediated behavior: implications for sex differences in schizophrenia. Psychiatry Res (1991) 1.22
Estrogen rapidly potentiates amphetamine-induced striatal dopamine release and rotational behavior during microdialysis. Neurosci Lett (1990) 1.19
Estrogen modulates synaptic N-methyl-D-aspartate receptor subunit distribution in the aged hippocampus. J Comp Neurol (2004) 1.19
Estrogen-related variations in human spatial and articulatory-motor skills. Psychoneuroendocrinology (1990) 1.16
Can estradiol modulate schizophrenic symptomatology? Schizophr Bull (1994) 1.15
Estrogen selectively increases tryptophan hydroxylase-2 mRNA expression in distinct subregions of rat midbrain raphe nucleus: association between gene expression and anxiety behavior in the open field. Biol Psychiatry (2006) 1.14
Estrogen enhances neurogenesis and behavioral recovery after stroke. J Cereb Blood Flow Metab (2010) 1.13
The role of serotonin in the NMDA receptor antagonist models of psychosis and cognitive impairment. Psychopharmacology (Berl) (2011) 1.09
Estrogen receptors stimulate brain region specific metabotropic glutamate receptors to rapidly initiate signal transduction pathways. J Chem Neuroanat (2011) 1.08
Sex steroid control of mood, mental state and memory. Clin Exp Pharmacol Physiol (1998) 1.06
Current outcome in schizophrenia: women vs men. Acta Psychiatr Scand (1986) 1.06
Effects of estrogen on brain development and neuroprotection--implications for negative symptoms in schizophrenia. Psychoneuroendocrinology (2003) 1.01
Steroid regulation of tryptophan hydroxylase protein in the dorsal raphe of macaques. Biol Psychiatry (2000) 1.01
Acute stimulatory effect of estradiol on striatal dopamine synthesis. J Neurochem (1995) 1.01
Estrogen, menstrual cycle phases, and psychopathology in women suffering from schizophrenia. Psychol Med (2007) 1.01
Neuroprotection of sex steroids. Minerva Endocrinol (2010) 0.99
A double-blind randomised placebo controlled trial of postnatal norethisterone enanthate: the effect on postnatal depression and serum hormones. Br J Obstet Gynaecol (1998) 0.98
Ovarian steroid regulation of tryptophan hydroxylase mRNA expression in rhesus macaques. J Neurosci (1996) 0.97
Adjunctive estrogen treatment in women with chronic schizophrenia: a double-blind, randomized, and placebo-controlled trial. Prog Neuropsychopharmacol Biol Psychiatry (2003) 0.95
Estrogen augmentation in schizophrenia: a quantitative review of current evidence. Schizophr Res (2012) 0.94
Paradoxical effects of GABA-A modulators may explain sex steroid induced negative mood symptoms in some persons. Neuroscience (2011) 0.93
Estrogen can protect neurons: modes of action. J Steroid Biochem Mol Biol (2002) 0.92
Abnormal Involuntary Movement Scale (AIMS). Psychopharmacol Bull (1988) 0.91
Estrogens and gonadal function in schizophrenia and related psychoses. Curr Top Behav Neurosci (2011) 0.88
Estrogen, cognitive function and negative symptoms in female schizophrenia. Neuropsychobiology (2006) 0.87
A clinical trial of the effects of estrogen in acutely psychotic women. Schizophr Res (1996) 0.85
Oestradiol modulation of serotonin reuptake transporter and serotonin metabolism in the brain of monkeys. J Neuroendocrinol (2013) 0.83
Oestrogen effects on dopaminergic function in striatum. Novartis Found Symp (2000) 0.83
Oestradiol enhances the vulnerability threshold for schizophrenia in women by an early effect on dopaminergic neurotransmission. Evidence from an epidemiological study and from animal experiments. Eur Arch Psychiatry Clin Neurosci (1991) 0.83
Estrogen affects cognition in women with psychosis. Psychiatry Res (2000) 0.83
Hormone modulation: a novel therapeutic approach for women with severe mental illness. Aust N Z J Psychiatry (2008) 0.82
Combination of estrogen and antipsychotics in the treatment of women with chronic schizophrenia: a double-blind, randomized, placebo-controlled clinical trial. Clin Schizophr Relat Psychoses (2013) 0.81
Role of estrogens in peripheral and cerebral glucose utilization. Rev Neurosci (2011) 0.80
Oestrogen effects in schizophrenia and their potential therapeutic implications--review. Arch Womens Ment Health (2002) 0.80
Estrogen therapy for depression in postmenopausal women. Int J Gynaecol Obstet (1999) 0.80
Neurochemistry of schizophrenia: the contribution of neuroimaging postmortem pathology and neurochemistry in schizophrenia. Curr Top Med Chem (2012) 0.78